| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 42 | 2023 | 778 | 5.920 |
Why?
|
| Lumbar Vertebrae | 28 | 2023 | 490 | 5.760 |
Why?
|
| Imaging, Three-Dimensional | 36 | 2023 | 222 | 4.570 |
Why?
|
| Low Back Pain | 11 | 2019 | 139 | 3.760 |
Why?
|
| Femur | 18 | 2023 | 393 | 3.340 |
Why?
|
| Intervertebral Disc | 11 | 2021 | 217 | 3.030 |
Why?
|
| Intervertebral Disc Degeneration | 9 | 2021 | 117 | 2.150 |
Why?
|
| Zygapophyseal Joint | 7 | 2019 | 44 | 2.110 |
Why?
|
| Hip Dislocation | 3 | 2020 | 64 | 1.980 |
Why?
|
| Acetabulum | 4 | 2020 | 198 | 1.930 |
Why?
|
| Range of Motion, Articular | 21 | 2023 | 707 | 1.770 |
Why?
|
| Bone Density | 6 | 2021 | 151 | 1.520 |
Why?
|
| Tibia | 13 | 2020 | 266 | 1.440 |
Why?
|
| Middle Aged | 41 | 2021 | 9962 | 1.420 |
Why?
|
| Male | 60 | 2023 | 15870 | 1.380 |
Why?
|
| Adult | 41 | 2021 | 8748 | 1.370 |
Why?
|
| Young Adult | 19 | 2021 | 1969 | 1.250 |
Why?
|
| Humans | 78 | 2023 | 29855 | 1.240 |
Why?
|
| Female | 46 | 2023 | 16429 | 1.220 |
Why?
|
| Lumbosacral Region | 6 | 2021 | 73 | 1.180 |
Why?
|
| Biomechanical Phenomena | 31 | 2023 | 680 | 1.170 |
Why?
|
| Femur Head | 4 | 2020 | 65 | 1.080 |
Why?
|
| Knee Joint | 13 | 2023 | 800 | 1.040 |
Why?
|
| Bone Transplantation | 12 | 2021 | 227 | 0.970 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 2 | 2018 | 235 | 0.960 |
Why?
|
| Baseball | 2 | 2022 | 107 | 0.890 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2023 | 60 | 0.880 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2021 | 1247 | 0.840 |
Why?
|
| Cadaver | 14 | 2020 | 362 | 0.840 |
Why?
|
| Spinal Fractures | 1 | 2021 | 62 | 0.770 |
Why?
|
| Spondylosis | 3 | 2017 | 32 | 0.760 |
Why?
|
| Cervical Vertebrae | 8 | 2021 | 352 | 0.740 |
Why?
|
| Weight-Bearing | 12 | 2016 | 168 | 0.710 |
Why?
|
| Spine | 3 | 2018 | 123 | 0.710 |
Why?
|
| Spinal Fusion | 9 | 2023 | 518 | 0.700 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2018 | 276 | 0.660 |
Why?
|
| Shoulder Joint | 3 | 2022 | 577 | 0.660 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2021 | 221 | 0.630 |
Why?
|
| Prosthesis Implantation | 2 | 2010 | 35 | 0.630 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 382 | 0.620 |
Why?
|
| X-Ray Microtomography | 6 | 2021 | 79 | 0.620 |
Why?
|
| Nucleus Pulposus | 1 | 2017 | 12 | 0.600 |
Why?
|
| Ligaments, Articular | 1 | 2018 | 104 | 0.590 |
Why?
|
| Flatfoot | 5 | 2016 | 5 | 0.570 |
Why?
|
| Cartilage, Articular | 5 | 2021 | 534 | 0.560 |
Why?
|
| Knee Injuries | 2 | 2020 | 228 | 0.560 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2023 | 696 | 0.560 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2007 | 103 | 0.550 |
Why?
|
| Transforming Growth Factor beta | 6 | 2007 | 124 | 0.550 |
Why?
|
| Manipulation, Spinal | 1 | 2016 | 5 | 0.540 |
Why?
|
| Torsion, Mechanical | 1 | 2016 | 4 | 0.540 |
Why?
|
| Proteoglycans | 3 | 2017 | 345 | 0.540 |
Why?
|
| Aged | 22 | 2023 | 9620 | 0.530 |
Why?
|
| Animals | 31 | 2021 | 4640 | 0.520 |
Why?
|
| Ligamentum Flavum | 1 | 2015 | 6 | 0.510 |
Why?
|
| Diskectomy | 2 | 2021 | 195 | 0.470 |
Why?
|
| Computer Simulation | 6 | 2021 | 219 | 0.460 |
Why?
|
| Femoracetabular Impingement | 4 | 2021 | 168 | 0.450 |
Why?
|
| Joint Instability | 6 | 2021 | 389 | 0.440 |
Why?
|
| Radiography | 12 | 2020 | 678 | 0.440 |
Why?
|
| Intra-Articular Fractures | 3 | 2022 | 16 | 0.410 |
Why?
|
| Aortic Aneurysm | 1 | 2012 | 12 | 0.410 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 16 | 0.410 |
Why?
|
| Rotation | 5 | 2022 | 142 | 0.400 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 165 | 0.390 |
Why?
|
| Osteotomy | 3 | 2022 | 164 | 0.390 |
Why?
|
| Bone Screws | 5 | 2023 | 181 | 0.370 |
Why?
|
| Adolescent | 4 | 2020 | 2334 | 0.370 |
Why?
|
| Pedicle Screws | 2 | 2023 | 17 | 0.370 |
Why?
|
| Arthrography | 1 | 2010 | 27 | 0.360 |
Why?
|
| Reference Values | 4 | 2016 | 231 | 0.350 |
Why?
|
| Cartilage Diseases | 2 | 2022 | 83 | 0.340 |
Why?
|
| Osseointegration | 3 | 2007 | 75 | 0.340 |
Why?
|
| Osteoarthritis | 4 | 2018 | 366 | 0.330 |
Why?
|
| Occipital Bone | 3 | 2016 | 13 | 0.330 |
Why?
|
| Fracture Healing | 4 | 2010 | 41 | 0.320 |
Why?
|
| Case-Control Studies | 2 | 2020 | 643 | 0.310 |
Why?
|
| Stress, Mechanical | 8 | 2021 | 169 | 0.310 |
Why?
|
| Bone Plates | 3 | 2018 | 55 | 0.310 |
Why?
|
| Spinal Diseases | 2 | 2006 | 150 | 0.300 |
Why?
|
| Models, Anatomic | 5 | 2016 | 52 | 0.300 |
Why?
|
| Tarsal Bones | 4 | 2016 | 7 | 0.290 |
Why?
|
| Elbow Joint | 2 | 2021 | 131 | 0.290 |
Why?
|
| Cohort Studies | 3 | 2019 | 1953 | 0.290 |
Why?
|
| Anthropometry | 3 | 2011 | 38 | 0.270 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2017 | 81 | 0.270 |
Why?
|
| Rabbits | 8 | 2021 | 283 | 0.270 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 60 | 0.270 |
Why?
|
| Allografts | 4 | 2022 | 180 | 0.260 |
Why?
|
| Dogs | 9 | 2007 | 261 | 0.260 |
Why?
|
| Bone Substitutes | 3 | 2015 | 26 | 0.260 |
Why?
|
| Posture | 2 | 2016 | 79 | 0.230 |
Why?
|
| Lower Extremity | 1 | 2023 | 38 | 0.210 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2002 | 6 | 0.210 |
Why?
|
| Electromagnetic Fields | 1 | 2002 | 13 | 0.210 |
Why?
|
| Electric Stimulation Therapy | 1 | 2002 | 47 | 0.210 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2022 | 5 | 0.210 |
Why?
|
| Osteonecrosis | 1 | 2022 | 19 | 0.200 |
Why?
|
| Equipment Design | 3 | 2017 | 186 | 0.200 |
Why?
|
| Wrist Joint | 1 | 2022 | 61 | 0.200 |
Why?
|
| Disease Progression | 2 | 2017 | 812 | 0.190 |
Why?
|
| Retrospective Studies | 3 | 2020 | 3325 | 0.190 |
Why?
|
| Calcification, Physiologic | 2 | 2011 | 21 | 0.190 |
Why?
|
| Athletes | 1 | 2021 | 76 | 0.190 |
Why?
|
| Atlanto-Occipital Joint | 2 | 2011 | 18 | 0.190 |
Why?
|
| Hip Joint | 4 | 2023 | 357 | 0.180 |
Why?
|
| Posterior Cruciate Ligament Reconstruction | 1 | 2020 | 5 | 0.180 |
Why?
|
| Ankle Joint | 2 | 2011 | 41 | 0.180 |
Why?
|
| Age Factors | 2 | 2015 | 854 | 0.180 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2020 | 23 | 0.180 |
Why?
|
| Rats | 8 | 2018 | 876 | 0.180 |
Why?
|
| Tomography, Spiral Computed | 1 | 2020 | 27 | 0.180 |
Why?
|
| Motion | 2 | 2018 | 23 | 0.170 |
Why?
|
| Femoral Fractures | 2 | 2015 | 42 | 0.170 |
Why?
|
| Pubic Bone | 1 | 2019 | 3 | 0.170 |
Why?
|
| Groin | 1 | 2019 | 4 | 0.170 |
Why?
|
| Pubic Symphysis | 1 | 2019 | 3 | 0.170 |
Why?
|
| Rotator Cuff | 1 | 2002 | 266 | 0.170 |
Why?
|
| Lordosis | 1 | 2020 | 42 | 0.170 |
Why?
|
| Osteogenesis, Distraction | 3 | 2005 | 13 | 0.170 |
Why?
|
| Suture Anchors | 1 | 2019 | 71 | 0.160 |
Why?
|
| Laminoplasty | 1 | 2018 | 1 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 4930 | 0.160 |
Why?
|
| Software | 3 | 2019 | 72 | 0.160 |
Why?
|
| Chronic Pain | 2 | 2019 | 112 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 532 | 0.160 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2018 | 1 | 0.160 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 18 | 0.150 |
Why?
|
| Algorithms | 3 | 2015 | 401 | 0.150 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 744 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 704 | 0.150 |
Why?
|
| Spondylolisthesis | 1 | 2018 | 52 | 0.150 |
Why?
|
| Hyperalgesia | 1 | 2018 | 45 | 0.150 |
Why?
|
| Athletic Injuries | 1 | 2019 | 180 | 0.150 |
Why?
|
| Salvage Therapy | 1 | 2017 | 36 | 0.150 |
Why?
|
| Radiculopathy | 1 | 2018 | 62 | 0.140 |
Why?
|
| Tibial Fractures | 2 | 2010 | 13 | 0.140 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 16 | 0.140 |
Why?
|
| Sex Characteristics | 3 | 2016 | 135 | 0.140 |
Why?
|
| Bone Matrix | 2 | 2015 | 28 | 0.140 |
Why?
|
| Prosthesis Design | 5 | 2019 | 494 | 0.140 |
Why?
|
| Arthroscopy | 2 | 2021 | 817 | 0.130 |
Why?
|
| Rotator Cuff Injuries | 1 | 2019 | 280 | 0.130 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 112 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2019 | 1823 | 0.130 |
Why?
|
| Compressive Strength | 2 | 2013 | 29 | 0.130 |
Why?
|
| Internal Fixators | 3 | 2012 | 52 | 0.130 |
Why?
|
| Bone Development | 2 | 2015 | 37 | 0.130 |
Why?
|
| Biomimetic Materials | 1 | 2015 | 8 | 0.130 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 22 | 0.130 |
Why?
|
| Integrin alpha5beta1 | 1 | 2014 | 3 | 0.130 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2014 | 5 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 29 | 0.120 |
Why?
|
| Models, Animal | 5 | 2012 | 128 | 0.120 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 11 | 0.120 |
Why?
|
| Growth Substances | 3 | 1999 | 41 | 0.120 |
Why?
|
| Neuropeptides | 3 | 1999 | 30 | 0.120 |
Why?
|
| Muscle Proteins | 3 | 1999 | 30 | 0.120 |
Why?
|
| Postoperative Complications | 3 | 2010 | 957 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2010 | 327 | 0.120 |
Why?
|
| Osteochondritis Dissecans | 1 | 2015 | 27 | 0.120 |
Why?
|
| Foot Orthoses | 1 | 2014 | 12 | 0.120 |
Why?
|
| Transplantation, Homologous | 5 | 2020 | 279 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 46 | 0.120 |
Why?
|
| Humerus | 1 | 2015 | 101 | 0.120 |
Why?
|
| Peptides | 3 | 1999 | 98 | 0.120 |
Why?
|
| Torque | 4 | 2017 | 29 | 0.120 |
Why?
|
| Scapula | 1 | 2014 | 81 | 0.120 |
Why?
|
| Gait | 2 | 2016 | 406 | 0.110 |
Why?
|
| Ilium | 1 | 2014 | 31 | 0.110 |
Why?
|
| Osteogenesis | 3 | 2015 | 103 | 0.110 |
Why?
|
| Bone Regeneration | 3 | 2004 | 75 | 0.110 |
Why?
|
| Glenoid Cavity | 1 | 2013 | 34 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 803 | 0.110 |
Why?
|
| Titanium | 2 | 2005 | 197 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 27 | 0.110 |
Why?
|
| External Fixators | 2 | 2003 | 11 | 0.110 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2012 | 1 | 0.100 |
Why?
|
| Osteoarthritis, Spine | 1 | 2012 | 7 | 0.100 |
Why?
|
| Calcium Phosphates | 2 | 2015 | 27 | 0.100 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2012 | 9 | 0.100 |
Why?
|
| Time Factors | 4 | 2010 | 1641 | 0.100 |
Why?
|
| Computers | 2 | 2022 | 26 | 0.100 |
Why?
|
| Mechanical Phenomena | 1 | 2011 | 22 | 0.100 |
Why?
|
| Collagen | 1 | 2011 | 102 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 131 | 0.090 |
Why?
|
| Pregnancy | 1 | 2012 | 388 | 0.090 |
Why?
|
| Mucins | 3 | 1999 | 6 | 0.090 |
Why?
|
| Atlanto-Axial Joint | 1 | 2010 | 18 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 258 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2018 | 124 | 0.090 |
Why?
|
| Epiphyses | 2 | 2020 | 13 | 0.090 |
Why?
|
| Acupuncture Points | 1 | 2010 | 1 | 0.090 |
Why?
|
| Electroacupuncture | 1 | 2010 | 1 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2012 | 224 | 0.090 |
Why?
|
| Fracture Fixation, Internal | 1 | 2011 | 72 | 0.090 |
Why?
|
| Materials Testing | 3 | 2017 | 136 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 558 | 0.090 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 144 | 0.090 |
Why?
|
| Biometry | 1 | 2009 | 8 | 0.090 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 8 | 0.090 |
Why?
|
| Goblet Cells | 2 | 1999 | 2 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 40 | 0.090 |
Why?
|
| Models, Biological | 3 | 2014 | 347 | 0.090 |
Why?
|
| Foot | 1 | 2009 | 31 | 0.090 |
Why?
|
| Sex Factors | 1 | 2010 | 498 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2011 | 685 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 5 | 2007 | 63 | 0.080 |
Why?
|
| Calcaneus | 3 | 2013 | 7 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2009 | 152 | 0.080 |
Why?
|
| Talus | 3 | 2013 | 11 | 0.070 |
Why?
|
| Observer Variation | 2 | 2018 | 119 | 0.070 |
Why?
|
| Calcium Sulfate | 1 | 2007 | 20 | 0.070 |
Why?
|
| Prognosis | 1 | 2010 | 874 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 364 | 0.070 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2006 | 14 | 0.070 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2006 | 6 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2006 | 66 | 0.070 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 13 | 0.070 |
Why?
|
| Thrombin | 1 | 2006 | 12 | 0.070 |
Why?
|
| Cicatrix | 1 | 2006 | 12 | 0.070 |
Why?
|
| Hemostatics | 1 | 2006 | 12 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2006 | 46 | 0.070 |
Why?
|
| Bone Marrow | 2 | 2005 | 78 | 0.070 |
Why?
|
| Torsion Abnormality | 4 | 2007 | 10 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2014 | 857 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 245 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 411 | 0.060 |
Why?
|
| Laminectomy | 1 | 2006 | 64 | 0.060 |
Why?
|
| Rats, Nude | 2 | 2015 | 4 | 0.060 |
Why?
|
| Prosthesis Failure | 3 | 2017 | 530 | 0.060 |
Why?
|
| Fracture Fixation | 1 | 2004 | 26 | 0.060 |
Why?
|
| Equipment Failure Analysis | 2 | 2015 | 106 | 0.060 |
Why?
|
| Silicones | 1 | 2004 | 8 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 1999 | 81 | 0.060 |
Why?
|
| Skull | 1 | 2004 | 25 | 0.060 |
Why?
|
| Metatarsal Bones | 2 | 2014 | 7 | 0.060 |
Why?
|
| Bone Diseases | 1 | 2004 | 24 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 106 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 6 | 0.060 |
Why?
|
| Bone Cements | 1 | 2004 | 90 | 0.060 |
Why?
|
| Pelvis | 1 | 2023 | 30 | 0.060 |
Why?
|
| Finite Element Analysis | 1 | 2023 | 44 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2004 | 84 | 0.050 |
Why?
|
| Equipment Reuse | 1 | 2003 | 3 | 0.050 |
Why?
|
| Tendons | 1 | 2005 | 223 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 329 | 0.050 |
Why?
|
| Ultrasonic Therapy | 1 | 2002 | 20 | 0.050 |
Why?
|
| Aging | 1 | 2012 | 1630 | 0.050 |
Why?
|
| Mice | 4 | 2012 | 1629 | 0.050 |
Why?
|
| Iodoacetic Acid | 1 | 2021 | 2 | 0.050 |
Why?
|
| Ultrasonics | 1 | 2002 | 16 | 0.050 |
Why?
|
| Musculoskeletal System | 1 | 2021 | 6 | 0.050 |
Why?
|
| Menisci, Tibial | 1 | 2003 | 172 | 0.050 |
Why?
|
| Cartilage | 1 | 2022 | 154 | 0.050 |
Why?
|
| Benchmarking | 1 | 2021 | 42 | 0.050 |
Why?
|
| Elasticity | 3 | 2007 | 40 | 0.050 |
Why?
|
| Knee | 1 | 2020 | 44 | 0.040 |
Why?
|
| Benzophenones | 1 | 2019 | 27 | 0.040 |
Why?
|
| Ketones | 1 | 2019 | 20 | 0.040 |
Why?
|
| Polymers | 1 | 2019 | 40 | 0.040 |
Why?
|
| Rectus Abdominis | 1 | 2019 | 5 | 0.040 |
Why?
|
| Hernia | 1 | 2019 | 7 | 0.040 |
Why?
|
| Ligaments | 1 | 2019 | 15 | 0.040 |
Why?
|
| Thigh | 1 | 2019 | 35 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 58 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 108 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 397 | 0.040 |
Why?
|
| Colon | 1 | 1999 | 149 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 14 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 10 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2018 | 15 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1998 | 11 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2018 | 28 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2018 | 8 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 22 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2018 | 25 | 0.040 |
Why?
|
| Nerve Growth Factor | 1 | 2018 | 33 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 69 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 58 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 108 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 1859 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 364 | 0.040 |
Why?
|
| Body Weight | 2 | 2012 | 132 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 355 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 256 | 0.030 |
Why?
|
| Japan | 1 | 2015 | 11 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 384 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 350 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 230 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 463 | 0.030 |
Why?
|
| Trefoil Factor-3 | 3 | 1999 | 3 | 0.030 |
Why?
|
| Trefoil Factor-2 | 3 | 1999 | 4 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 30 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2014 | 20 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 48 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 97 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 970 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 84 | 0.030 |
Why?
|
| Isografts | 1 | 2014 | 1 | 0.030 |
Why?
|
| Hyaline Cartilage | 1 | 2013 | 15 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2002 | 3561 | 0.030 |
Why?
|
| Foot Diseases | 1 | 2013 | 1 | 0.030 |
Why?
|
| Posterior Tibial Tendon Dysfunction | 1 | 2013 | 1 | 0.030 |
Why?
|
| Foot Joints | 1 | 2013 | 5 | 0.030 |
Why?
|
| Physical Examination | 1 | 2014 | 117 | 0.030 |
Why?
|
| Arthroplasty, Replacement | 1 | 2014 | 149 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2012 | 29 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2012 | 58 | 0.030 |
Why?
|
| Body Height | 1 | 2012 | 33 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 73 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 297 | 0.020 |
Why?
|
| Walking | 1 | 2014 | 254 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1462 | 0.020 |
Why?
|
| Knee Prosthesis | 1 | 2014 | 244 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 232 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 45 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 436 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 542 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 143 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 654 | 0.020 |
Why?
|
| Subtalar Joint | 1 | 2009 | 3 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 618 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 2467 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1379 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 59 | 0.020 |
Why?
|
| Orthopedic Equipment | 1 | 2006 | 7 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 29 | 0.020 |
Why?
|
| Movement | 1 | 2007 | 146 | 0.020 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2007 | 121 | 0.020 |
Why?
|
| Cattle | 1 | 2006 | 220 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2005 | 28 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2005 | 14 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2005 | 14 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2005 | 9 | 0.020 |
Why?
|
| Bony Callus | 1 | 2005 | 8 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2007 | 508 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 24 | 0.020 |
Why?
|
| Anisotropy | 1 | 2005 | 60 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2005 | 70 | 0.020 |
Why?
|
| Cisplatin | 1 | 2005 | 92 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 197 | 0.020 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2004 | 24 | 0.020 |
Why?
|
| Apatites | 1 | 2004 | 1 | 0.010 |
Why?
|
| Microradiography | 1 | 2004 | 4 | 0.010 |
Why?
|
| Tissue Preservation | 1 | 2004 | 6 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2005 | 51 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 7 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2003 | 31 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 84 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 168 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2002 | 5 | 0.010 |
Why?
|
| Quality Control | 1 | 2002 | 45 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 456 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 120 | 0.010 |
Why?
|
| Mucin-2 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Mucin-3 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1999 | 3 | 0.010 |
Why?
|
| Diphtheria Toxin | 1 | 1999 | 2 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 8 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 26 | 0.010 |
Why?
|
| Dextran Sulfate | 1 | 1999 | 11 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1999 | 29 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 135 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 196 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 248 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1999 | 325 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 1998 | 8 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 149 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 130 | 0.010 |
Why?
|
| Protein Binding | 1 | 1998 | 125 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 285 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 87 | 0.010 |
Why?
|